Letter to the Editor: Will Vitamin E Be the Hope of Patients With NASH and Advanced Fibrosis? The Reliability Is Worth Discussing

被引：1
|
作者：
He, Jian [1 ]
Leng, Ai-Min [1 ]
机构：
[1] Cent S Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China
来源：
HEPATOLOGY | 2019年 / 70卷 / 02期
关键词：
FUTURE;
D O I：
10.1002/hep.30603
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：751 / 751
页数：1
相关论文
共 50 条
  • [1] Letter to the Editor: Will Vitamin E Be the Hope of Patients With NASH and Advanced Fibrosis? The Reliability Is Worth Discussing Reply
    Vilar-Gomez, Eduardo
    Chalasani, Naga
    HEPATOLOGY, 2019, 70 (02) : 752 - 752
  • [2] Letter to the editor: Liver outcomes after bariatric surgery in patients with NASH and advanced fibrosis
    Jindal, Ankur
    HEPATOLOGY, 2022, 76 (02) : E42 - E42
  • [3] Letter to the editor: In patients with established NASH cirrhosis, is there no role of weight reduction in reversing fibrosis?
    Kumar, Ashish
    Sharma, Praveen
    Arora, Anil
    HEPATOLOGY, 2022, 76 (01) : E3 - E4
  • [4] Vitamin E therapy in patients with NASH
    Yoneda, M
    Hasegawa, T
    Nakamura, K
    Tamano, M
    Kono, T
    Terano, A
    HEPATOLOGY, 2004, 39 (02) : 568 - 568
  • [5] Letter to the Editor: Noninvasive Markers of Advanced Liver Fibrosis in HBV/HIV Coinfected Patients
    Huang, Rui
    Wang, Jian
    Yan, Xiaomin
    Zhang, Zhaoping
    Wu, Chao
    HEPATOLOGY, 2019, 70 (06) : 2240 - 2241
  • [6] Vitamin E therapy in patients with NASH - More on vitamin E therapy - Reply
    McClain, C
    Hill, D
    Kugelmas, M
    HEPATOLOGY, 2004, 39 (02) : 569 - 570
  • [7] Association of HFE mutations and advanced fibrosis in patients with NASH
    Nelson, JE
    Bhattacharya, R
    Lindor, KD
    Raaka, S
    Heathcote, J
    Shaffer, E
    Rulyak, S
    Kowdley, KV
    HEPATOLOGY, 2005, 42 (04) : 616A - 616A
  • [8] Letter to the Editor: Noninvasive Markers of Advanced Liver Fibrosis in HBV/HIV Coinfected Patients Reply
    Sterling, Richard K.
    King, Wendy C.
    Kleiner, David E.
    HEPATOLOGY, 2019, 70 (06) : 2241 - 2242
  • [9] Letter to the Editor: Cilofexor in Patients With Nonalcoholic Steatohepatitis (NASH): Is It Really Effective?
    Jindal, Ankur
    Sarin, Shiv K.
    HEPATOLOGY, 2020, 72 (06) : 2240 - 2241
  • [10] Clinical Model for NASH or Advanced Fibrosis in Patients With Diabetes and NAFLD
    Bazick, Jessica
    Donithan, Michele
    Neuschwander-Tetri, Brent A.
    Kleiner, David E.
    Brunt, Elizabeth
    Wilson, Laura
    Doo, Edward
    Lavine, Joel E.
    Loomba, Rohit
    GASTROENTEROLOGY, 2014, 146 (05) : S948 - S948
12345